How does cytosine demand correlate with nucleotide metabolism research and nucleic acid drug development?

How does cytosine demand correlate with nucleotide metabolism research and nucleic acid drug development?
Cytosine is one of the four fundamental bases in DNA and RNA, making it essential not only in biological research but also in the synthesis of nucleoside-based pharmaceuticals. In nucleotide metabolism, cytosine is a building block for CTP and dTMP, which are critical for DNA replication—this underpins its use in antiviral and anticancer drugs that target nucleic acid synthesis. The push toward expanded genetic alphabets, such as the recent addition of four synthetic bases to the natural four, highlights ongoing innovation in nucleic acid chemistry, potentially opening new niches for cytosine derivatives. For market watchers, cytosine demand is thus tied to both established antiviral APIs and emerging nucleic acid therapeutics, where China's role as a low-cost producer of cytosine and its derivatives like 5-fluorocytosine remains pivotal.